Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phio Pharmaceuticals Corp (NQ: PHIO )

4.200 -0.470 (-10.06%)
Streaming Delayed Price Updated: 10:07 AM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,099
Open 4.610
Bid (Size) 4.420 (1)
Ask (Size) 4.550 (5)
Prev. Close 4.670
Today's Range 4.200 - 4.610
52wk Range 0.5000 - 6.195
Shares Outstanding 4,591,700
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds
Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company... 
Via Newsfile
Topics Regulatory Compliance
Exposures Legal Regulatory
Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762
Five sites across the U.S. are now participating in the Phase 1b study Marlborough, Massachusetts--(Newsfile Corp. - July 8,... 
Via Newsfile

Performance

YTD
+445.67%
+445.67%
1 Month
+473.77%
+473.77%
3 Month
+531.01%
+531.01%
6 Month
+538.69%
+538.69%
1 Year
+53.85%
+53.85%

More News

Read More
Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds
Via Newsfile
Phio Pharmaceuticals Announces Reverse Stock Split
Via Newsfile
PHIO Stock Earnings: Phio Pharma Reported Results for Q1 2024
Via InvestorPlace
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762
Via Newsfile
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
Via Newsfile
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
From Phio Pharmaceuticals Corp.
Via GlobeNewswire
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?
Via Benzinga
PHIO Stock Earnings: Phio Pharma Beats EPS for Q4 2023
Via InvestorPlace
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
From Phio Pharmaceuticals Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Dow Surges 100 Points; Ciena Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.